Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses

Sphingosine-1-phosphate receptor modulators and anti-CD20 treatment are widely used disease-modifying treatments for multiple sclerosis. Unfortunately, they may impair the patient’s ability to mount sufficient humoral and T-cellular responses to vaccination, which is of special relevance in the cont...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Christina Woopen, Urszula Konofalska, Katja Akgün, Tjalf Ziemssen
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2022-07-01
סדרה:	Frontiers in Immunology
נושאים:	multiple sclerosis sphingosine-1-receptor modulators (S1PR) neutralizing antibody prophylaxis severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19)
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.897748/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!